TRIM37 and neoplasm: Groups of mice were subcutaneously injected with control, TRIM37-overexpressing, or TRIM37-silenced PANC-1 cells, and the mice were then treated with 5-FU (150 mg/kg) twice per week, beginning when the tumor reached 0.5 cm in diameter.